The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts - PubMed
- ️Tue Jan 01 2008
doi: 10.1371/journal.pone.0001970.
Andrea Pellagatti, Maryam Nikpour, Beena Pushkaran, Carrie Fidler, Helen Cattan, Tim J Littlewood, Luca Malcovati, Matteo G Della Porta, Martin Jädersten, Sally Killick, Aristoteles Giagounidis, David Bowen, Eva Hellström-Lindberg, Mario Cazzola, James S Wainscoat
Affiliations
- PMID: 18398482
- PMCID: PMC2276313
- DOI: 10.1371/journal.pone.0001970
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
Jacqueline Boultwood et al. PLoS One. 2008.
Abstract
Refractory Anemia with Ring Sideroblasts (RARS) is an acquired myelodysplastic syndrome (MDS) characterized by an excess iron accumulation in the mitochondria of erythroblasts. The pathogenesis of RARS and the cause of this unusual pattern of iron deposition remain unknown. We considered that the inherited X-linked sideroblastic anemia with ataxia (XLSA/A) might be informative for the acquired disorder, RARS. XLSA/A is caused by partial inactivating mutations of the ABCB7 ATP-binding cassette transporter gene, which functions to enable transport of iron from the mitochondria to the cytoplasm. Furthermore, ABCB7 gene silencing in HeLa cells causes an accumulation of iron in the mitochondria. We have studied the role of ABCB7 in RARS by DNA sequencing, methylation studies, and gene expression studies in primary CD34(+) cells and in cultured erythroblasts. The DNA sequence of the ABCB7 gene is normal in patients with RARS. We have investigated ABCB7 gene expression levels in the CD34(+) cells of 122 MDS cases, comprising 35 patients with refractory anemia (RA), 33 patients with RARS and 54 patients with RA with excess blasts (RAEB), and in the CD34(+) cells of 16 healthy controls. We found that the expression levels of ABCB7 are significantly lower in the RARS group. RARS is thus characterized by lower levels of ABCB7 gene expression in comparison to other MDS subtypes. Moreover, we find a strong relationship between increasing percentage of bone marrow ring sideroblasts and decreasing ABCB7 gene expression levels. Erythroblast cell cultures confirm the low levels of ABCB7 gene expression levels in RARS. These data provide an important link between inherited and acquired forms of sideroblastic anemia and indicate that ABCB7 is a strong candidate gene for RARS.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures

(A) ABCB7 expression levels in the CD34+ cells from healthy controls and MDS patients with RA, RAEB and RARS. (B) ABCB7 expression levels and percentage of ring sideroblasts in the bone marrow. (C) ABCB7 expression levels in cultured erythroblasts from healthy controls and MDS patients with RA and RARS. The boxes represent the 25th, 50th and 75th percentiles, the bars correspond to the 10th and 90th percentiles.

Similar articles
-
Nikpour M, Scharenberg C, Liu A, Conte S, Karimi M, Mortera-Blanco T, Giai V, Fernandez-Mercado M, Papaemmanuil E, Högstrand K, Jansson M, Vedin I, Wainscoat JS, Campbell P, Cazzola M, Boultwood J, Grandien A, Hellström-Lindberg E. Nikpour M, et al. Leukemia. 2013 Apr;27(4):889-896. doi: 10.1038/leu.2012.298. Epub 2012 Oct 16. Leukemia. 2013. PMID: 23070040 Free PMC article.
-
Nikpour M, Pellagatti A, Liu A, Karimi M, Malcovati L, Gogvadze V, Forsblom AM, Wainscoat JS, Cazzola M, Zhivotovsky B, Grandien A, Boultwood J, Hellström-Lindberg E. Nikpour M, et al. Br J Haematol. 2010 Jun;149(6):844-54. doi: 10.1111/j.1365-2141.2010.08174.x. Epub 2010 Apr 12. Br J Haematol. 2010. PMID: 20408843
-
Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, Arosio P. Cazzola M, et al. Blood. 2003 Mar 1;101(5):1996-2000. doi: 10.1182/blood-2002-07-2006. Epub 2002 Oct 24. Blood. 2003. PMID: 12406866
-
Refractory anemia with ring sideroblasts.
Malcovati L, Cazzola M. Malcovati L, et al. Best Pract Res Clin Haematol. 2013 Dec;26(4):377-85. doi: 10.1016/j.beha.2013.09.005. Epub 2013 Oct 1. Best Pract Res Clin Haematol. 2013. PMID: 24507814 Review.
-
Patnaik MM, Tefferi A. Patnaik MM, et al. Am J Hematol. 2019 Apr;94(4):475-488. doi: 10.1002/ajh.25397. Epub 2019 Jan 24. Am J Hematol. 2019. PMID: 30618061 Free PMC article. Review.
Cited by
-
Mies A, Hermine O, Platzbecker U. Mies A, et al. Curr Hematol Malig Rep. 2016 Dec;11(6):416-424. doi: 10.1007/s11899-016-0347-9. Curr Hematol Malig Rep. 2016. PMID: 27595736 Review.
-
A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich's ataxia.
Campos OA, Attar N, Cheng C, Vogelauer M, Mallipeddi NV, Schmollinger S, Matulionis N, Christofk HR, Merchant SS, Kurdistani SK. Campos OA, et al. Sci Adv. 2021 Dec 17;7(51):eabj9889. doi: 10.1126/sciadv.abj9889. Epub 2021 Dec 17. Sci Adv. 2021. PMID: 34919435 Free PMC article.
-
Ochi T, Fujiwara T, Ono K, Suzuki C, Nikaido M, Inoue D, Kato H, Onodera K, Ichikawa S, Fukuhara N, Onishi Y, Yokoyama H, Nakamura Y, Harigae H. Ochi T, et al. Sci Rep. 2022 Aug 26;12(1):14562. doi: 10.1038/s41598-022-18921-2. Sci Rep. 2022. PMID: 36028755 Free PMC article.
-
Baratti MO, Moreira YB, Traina F, Costa FF, Verjovski-Almeida S, Olalla-Saad ST. Baratti MO, et al. BMC Med Genomics. 2010 Jul 15;3:30. doi: 10.1186/1755-8794-3-30. BMC Med Genomics. 2010. PMID: 20633296 Free PMC article.
-
Sato K, Torimoto Y, Hosoki T, Ikuta K, Takahashi H, Yamamoto M, Ito S, Okamura N, Ichiki K, Tanaka H, Shindo M, Hirai K, Mizukami Y, Otake T, Fujiya M, Sasaki K, Kohgo Y. Sato K, et al. Int J Hematol. 2011 Mar;93(3):311-318. doi: 10.1007/s12185-011-0786-y. Epub 2011 Mar 8. Int J Hematol. 2011. PMID: 21380928
References
-
- Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649–1660. - PubMed
-
- Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes. Hematology (Am Soc Hematol Educ Program) 2002:136–161. - PubMed
-
- Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood. 2003;101:1996–2000. - PubMed
-
- Breccia M, Carmosino I, Biondo F, Mancini M, Russo E, et al. Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes. Leuk Res. 2006;30:178–182. - PubMed
-
- Hines JD, Grasso JA. The sideroblastic anemias. Semin Hematol. 1970;7:86–106. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous